News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Listen to the New Episode of Lung Cancer Considered on the FDA Approval of Taletrectinib for ROS1-Positive NSCLC – IASLC
IASLC/LinkedIn
Jun 26, 2025, 06:06

Listen to the New Episode of Lung Cancer Considered on the FDA Approval of Taletrectinib for ROS1-Positive NSCLC – IASLC

International Association for the Study of Lung Cancer shared a post on LinkedIn:

“The FDA has approved taletrectinib, a next-generation ROS1 inhibitor for NSCLC. But how does this new therapy compare with existing options—and where does it fit in the treatment landscape?

In this Lung Cancer Considered episode, Dr. Stephen Liu speaks with Dr. Enriqueta Felip and Dr. Jorge Nieva to break down the data behind the approval and discuss how clinicians can thoughtfully integrate taletrectinib into practice.

Listen now.”

More posts featuring IASLC.

cancer Enriqueta Felip FDA IASLC International Association for the Study of Lung Cancer Jorge Nieva Lung Cancer Considered NSCLC OncoDaily Oncology Stephen Liu Taletrectinib
Special Coverage
Drugs
Jul 19, 2025, 07:08
Datopotamab Deruxtecan-dlnk (Datroway) Updates 2025: Uses in cancer, Side effects, Dosage, Expectations and More
Blog
Jul 19, 2025, 02:39
Alisher Kahharov: Training at the Prestigious Saint-Louis Hospital in Paris
Blog
Jul 19, 2025, 02:07
Bernard A. Fox: Back in Taiwan - Sharing the Next Frontier in Cancer Immunotherapy at Grand Rounds
Blog
Jul 19, 2025, 02:00
Akash Maniam: How Best to De-Escalate Excellent Responders and Intensify Those Who Don't
Blog
Jul 18, 2025, 21:37
Zeynep Irem Ozay: Presentation by Ruchi Agarwal on Global Disparities in Clinical Trial Availability for Renal Cell Carcinoma
Insight
Jul 18, 2025, 21:36
Major disparities in access to Molecular Tumour Boards - Lung Cancer Europe
Oncolibrary
Jul 18, 2025, 21:35
Top 5 AI Tools for Medical Oncologists
Blog
Jul 18, 2025, 20:11
From Lab to Stage: Mastering Research Presentations as a PhD student - Manchester Cancer Research Centre
Blog
Jul 18, 2025, 19:49
Final Call for Discounted Registration to IASLC 2025 World Conference on Lung Cancer
Science
Jul 18, 2025, 19:26
Alfredo Addeo: A True Game Changer in Targeted Therapy for Lung Cancer
Blog
Jul 18, 2025, 19:23
Above and Beyond Awards ceremony at The Institute of Cancer Research
Blog
Jul 18, 2025, 19:04
"Belantamab Mafodotin Gives Patients a Chance," Says Diane Moran - International Myeloma Foundation